RPS6P3 and viral infectious disease: Upon viral infection, lnc-RPS6P3 inhibits oligomerization of NP, leading to a reduction in vRNP activity and interferes the binding of NS1 to RIG-I, leading to increased K63 ubiquitination of RIG-I, which activates the antiviral innate response and inhibits influenza virus replication.